Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30054-8. doi: 10.1016/j.hemonc.2019.08.001. [Epub ahead of print]

2.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2322-2329. doi: 10.1016/j.bbmt.2019.05.002. Epub 2019 May 6.

3.

Foxp3 expression in induced T regulatory cells derived from human umbilical cord blood vs. adult peripheral blood.

Do JS, Zhong F, Huang AY, Van't Hof WJ, Finney M, Laughlin MJ.

Bone Marrow Transplant. 2018 Dec;53(12):1568-1577. doi: 10.1038/s41409-018-0205-6. Epub 2018 May 9.

PMID:
29743573
4.

Quantitative Lateral Flow Assays for Salivary Biomarker Assessment: A Review.

Miočević O, Cole CR, Laughlin MJ, Buck RL, Slowey PD, Shirtcliff EA.

Front Public Health. 2017 Jun 14;5:133. doi: 10.3389/fpubh.2017.00133. eCollection 2017. Review.

5.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JH, Auletta J, Komanduri KV, Lindemans C, Riches ML.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1636-1645. doi: 10.1016/j.bbmt.2016.06.012. Epub 2016 Jun 22.

6.

Elderly woman with headache. Giant cell arteritis/temporal arteritis.

Lindor RA, Laughlin MJ Jr, Sadosty AT.

Ann Emerg Med. 2015 May;65(5):614, 622. doi: 10.1016/j.annemergmed.2014.07.001. No abstract available.

PMID:
25910765
7.

Salivary cortisol results obtainable within minutes of sample collection correspond with traditional immunoassays.

Shirtcliff EA, Buck RL, Laughlin MJ, Hart T, Cole CR, Slowey PD.

Clin Ther. 2015 Mar 1;37(3):505-14. doi: 10.1016/j.clinthera.2015.02.014. Epub 2015 Mar 12.

8.

RNAPro•SAL: a device for rapid and standardized collection of saliva RNA and proteins.

Chiang SH, Thomas GA, Liao W, Grogan T, Buck RL, Fuentes L, Yakob M, Laughlin MJ, Schafer C, Nazmul-Hossain A, Wei F, Elashoff D, Slowey PD, Wong DT.

Biotechniques. 2015 Feb 1;58(2):69-76. doi: 10.2144/000114254. eCollection 2015 Feb.

9.

Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status.

Nagalla SR, Snyder CK, Michaels JE, Laughlin MJ, Roberts CT, Balaji M, Balaji V, Seshiah V, Rao PV.

Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):155-9. doi: 10.4103/2230-8210.140226.

10.

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M.

Biol Blood Marrow Transplant. 2015 Apr;21(4):688-95. doi: 10.1016/j.bbmt.2014.12.017. Epub 2014 Dec 24.

11.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ; Graft-vs-Host Disease Working Committee of the CIBMTR.

Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74. doi: 10.1016/j.bbmt.2014.10.021. Epub 2014 Oct 30.

12.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W, Alpdogan O, Cashen A, Dandoy C, Finke R, Gale R, Gibson J, Hsu JW, Janakiraman N, Laughlin MJ, Lill M, Cairo MS, Munker R, Rowlings PA, Schouten HC, Shea TC, Stiff PJ, Waller EK.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1729-36. doi: 10.1016/j.bbmt.2014.06.036. Epub 2014 Jul 5.

13.

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1418-25. doi: 10.1016/j.bbmt.2014.05.021. Epub 2014 Jun 2.

14.

Ultrasound evaluation of appendicitis: importance of the 3 × 2 table for outcome reporting.

Fedko M, Bellamkonda VR, Bellolio MF, Hess EP, Lohse CM, Laack TA, Laughlin MJ Jr, Campbell RL.

Am J Emerg Med. 2014 Apr;32(4):346-8. doi: 10.1016/j.ajem.2013.12.052. Epub 2014 Jan 3.

PMID:
24512887
15.

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

Sabloff M, Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP, Saber W.

Biol Blood Marrow Transplant. 2014 Mar;20(3):421-4. doi: 10.1016/j.bbmt.2013.11.032. Epub 2013 Dec 7.

16.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR.

Biol Blood Marrow Transplant. 2014 Feb;20(2):202-8. doi: 10.1016/j.bbmt.2013.10.023. Epub 2013 Nov 1.

17.

Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.

Brunstein CG, McKenna DH, DeFor TE, Sumstad D, Paul P, Weisdorf DJ, Ratajczak M, Laughlin MJ, Wagner JE.

Biol Blood Marrow Transplant. 2013 Oct;19(10):1474-9. doi: 10.1016/j.bbmt.2013.07.016. Epub 2013 Jul 25.

18.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, Eapen M, Champlin RE.

Blood. 2013 Mar 28;121(13):2567-73. doi: 10.1182/blood-2012-08-453860. Epub 2013 Jan 29.

19.

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ.

Blood. 2013 Jan 31;121(5):752-8. doi: 10.1182/blood-2012-08-449108. Epub 2012 Dec 9.

20.

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ, Weisdorf DJ, Woolfrey A, Wagner JE.

Blood. 2012 Jun 7;119(23):5591-8. doi: 10.1182/blood-2011-12-400630. Epub 2012 Apr 10.

21.

Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.

Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, Lazarus HM, Cooper BW, Gerson SL, Barr P, Tse WW, Curtis C, Fanning LR, Creger RJ, Carlson-Barko JM, Laughlin MJ.

Bone Marrow Transplant. 2012 Jul;47(7):924-33. doi: 10.1038/bmt.2011.195. Epub 2011 Oct 17.

22.

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V; Eurocord-European Group for Blood and Marrow Transplantation; Netcord; Center for International Blood and Marrow Transplant Research.

Lancet Oncol. 2011 Dec;12(13):1214-21. doi: 10.1016/S1470-2045(11)70260-1. Epub 2011 Oct 6.

23.

The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation.

Wu W, Kim CH, Liu R, Kucia M, Marlicz W, Greco N, Ratajczak J, Laughlin MJ, Ratajczak MZ.

Leukemia. 2012 Apr;26(4):736-45. doi: 10.1038/leu.2011.252. Epub 2011 Sep 20.

24.

A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Ratajczak MZ, Kim CH, Abdel-Latif A, Schneider G, Kucia M, Morris AJ, Laughlin MJ, Ratajczak J.

Leukemia. 2012 Jan;26(1):63-72. doi: 10.1038/leu.2011.242. Epub 2011 Sep 2. Review.

25.

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.

Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1869-73. doi: 10.1016/j.bbmt.2011.07.008. Epub 2011 Jul 20.

26.

Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells.

Ratajczak J, Zuba-Surma E, Klich I, Liu R, Wysoczynski M, Greco N, Kucia M, Laughlin MJ, Ratajczak MZ.

Leukemia. 2011 Aug;25(8):1278-85. doi: 10.1038/leu.2011.73. Epub 2011 Apr 12.

27.

Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.

Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM, Liu F, Kindwall-Keller TL, Cooper BW, Laughlin MJ, Creger RJ, Barr PM, Gerson SL, Kaplan D.

Biol Blood Marrow Transplant. 2011 Jul;17(7):970-8. doi: 10.1016/j.bbmt.2011.03.005. Epub 2011 Apr 11.

28.

Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.

Adler DS, Lazarus H, Nair R, Goldberg JL, Greco NJ, Lassar T, Laughlin MJ, Das H, Pompili VJ.

Front Biosci (Elite Ed). 2011 Jan 1;3:506-14.

29.

Reduced methyl-CpG protein binding contributing to miR-184 expression in umbilical cord blood CD4+ T-cells.

Weitzel RP, Lesniewski ML, Greco NJ, Laughlin MJ.

Leukemia. 2011 Jan;25(1):169-72. doi: 10.1038/leu.2010.227. Epub 2010 Oct 7. No abstract available.

PMID:
20927133
30.

Strategies to enhance umbilical cord blood stem cell engraftment in adult patients.

Delaney C, Ratajczak MZ, Laughlin MJ.

Expert Rev Hematol. 2010 Jun;3(3):273-83. doi: 10.1586/ehm.10.24. Review.

31.

Umbilical cord blood stem cells for myocardial repair and regeneration.

Greco N, Laughlin MJ.

Methods Mol Biol. 2010;660:29-52. doi: 10.1007/978-1-60761-705-1_3.

PMID:
20680811
32.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE; Center for International Blood and Marrow Transplant Research; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation); National Cord Blood Program of the New York Blood Center.

Lancet Oncol. 2010 Jul;11(7):653-60. doi: 10.1016/S1470-2045(10)70127-3.

33.

Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.

Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS.

Bone Marrow Transplant. 2011 Jan;46(1):70-6. doi: 10.1038/bmt.2010.83. Epub 2010 May 3.

35.

Extending cord blood transplant to adults: dealing with problems and results overall.

Brunstein CG, Laughlin MJ.

Semin Hematol. 2010 Jan;47(1):86-96. doi: 10.1053/j.seminhematol.2009.10.010. Review.

PMID:
20109616
36.

Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.

Finney MR, Fanning LR, Joseph ME, Goldberg JL, Greco NJ, Bhakta S, Winter DG, Forster M, Scheid PE, Sabe M, Pompili VJ, Laughlin MJ.

Cytotherapy. 2010;12(1):67-78. doi: 10.3109/14653240903300658.

PMID:
19878081
37.

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2010 Feb;16(2):253-62. doi: 10.1016/j.bbmt.2009.10.004. Epub 2009 Oct 12.

38.

Optimization of isolation and further characterization of umbilical-cord-blood-derived very small embryonic/ epiblast-like stem cells (VSELs).

Zuba-Surma EK, Klich I, Greco N, Laughlin MJ, Ratajczak J, Ratajczak MZ.

Eur J Haematol. 2010 Jan 1;84(1):34-46. doi: 10.1111/j.1600-0609.2009.01352.x. Epub 2009 Sep 14.

PMID:
19758351
39.

Umbilical cord blood transplantation for acute myeloid leukemia.

Advani AS, Laughlin MJ.

Curr Opin Hematol. 2009 Mar;16(2):124-8. doi: 10.1097/MOH.0b013e3283257a60. Review.

PMID:
19468274
40.

Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics.

Strunk CJ, Platzbecker U, Thiede C, Schaich M, Illmer T, Kang Z, Leahy P, Li C, Xie X, Laughlin MJ, Lazarus HM, Gerson SL, Bunting KD, Ehninger G, Tse W.

Am J Hematol. 2009 May;84(5):308-9. doi: 10.1002/ajh.21396.

41.

microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells.

Weitzel RP, Lesniewski ML, Haviernik P, Kadereit S, Leahy P, Greco NJ, Laughlin MJ.

Blood. 2009 Jun 25;113(26):6648-57. doi: 10.1182/blood-2008-09-181156. Epub 2009 Mar 13.

42.

Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.

Gama V, Gomez JA, Mayo LD, Jackson MW, Danielpour D, Song K, Haas AL, Laughlin MJ, Matsuyama S.

Cell Death Differ. 2009 May;16(5):758-69. doi: 10.1038/cdd.2009.6. Epub 2009 Feb 27.

43.

ISCT Presidential Editorial.

Laughlin MJ.

Cytotherapy. 2009;11(1):2. doi: 10.1080/14653240902796302. No abstract available.

PMID:
23200105
44.

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells.

Lesniewski ML, Haviernik P, Weitzel RP, Kadereit S, Kozik MM, Fanning LR, Yang YC, Hegerfeldt Y, Finney MR, Ratajczak MZ, Greco N, Paul P, Maciejewski J, Laughlin MJ.

Leukemia. 2008 Dec;22(12):2201-7. doi: 10.1038/leu.2008.234. Epub 2008 Sep 4.

PMID:
18769450
45.

New insights into cord blood stem cell transplantation.

Tse W, Bunting KD, Laughlin MJ.

Curr Opin Hematol. 2008 Jul;15(4):279-84. doi: 10.1097/MOH.0b013e328304ae2c. Review.

PMID:
18536563
46.

New developments with umbilical cord blood.

Bhakta S, Laughlin MJ.

Cytotherapy. 2008;10(2):105-7. doi: 10.1080/14653240801936306. No abstract available.

PMID:
18368588
47.

Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejection.

Fanning LR, Hegerfeldt Y, Tary-Lehmann M, Lesniewski M, Maciejewski J, Weitzel RP, Kozik M, Finney M, Lazarus HM, Paul P, Ratajczak MZ, Meyerson HJ, Laughlin MJ.

Leukemia. 2008 Sep;22(9):1786-90. doi: 10.1038/leu.2008.55. Epub 2008 Mar 20. No abstract available.

PMID:
18354493
48.

Umbilical cord blood transplantation in adult myeloid leukemia.

Tse WW, Zang SL, Bunting KD, Laughlin MJ.

Bone Marrow Transplant. 2008 Mar;41(5):465-72. doi: 10.1038/sj.bmt.1705994. Epub 2008 Feb 4. Review.

PMID:
18246116
49.

Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.

van Heeckeren WJ, Fanning LR, Meyerson HJ, Fu P, Lazarus HM, Cooper BW, Tse WW, Kindwall-Keller TL, Jaroscak J, Finney MR, Fox RM, Solchaga L, Forster M, Creger RJ, Laughlin MJ.

Br J Haematol. 2007 Nov;139(3):464-74.

PMID:
17910637
50.

A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins.

Reca R, Cramer D, Yan J, Laughlin MJ, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ.

Stem Cells. 2007 Dec;25(12):3093-100. Epub 2007 Aug 23.

Supplemental Content

Loading ...
Support Center